Here are eight highlights:
1. In 2016, sales reached $19.8 million, up 33 percent from 2015.
2. VEXIM saw a 24 percent sales boost in Q4 2016, hitting $5.57 million.
3. VEXIM reported a 35 percent sales increase in Europe for 2016.
4. In France, the company leads the vertebral compression fracture treatment market. Compared to 2015, sales increased 48 percent in 2016 in France.
5. In the German market, sales increased 14 percent in 2016, compared to 2015.
6. Looking forward, VEXIM anticipates breaking even in 2017 to achieve a 30 percent to 35 percent sales increase.
7. In 2017, VEXIM will focus on developing new markets in Australia, South Africa and Brazil.
8. Since the technology’s launch in 2011, VEXIM reported the sale of 42,300 SpineJack units, as of Dec. 31, 2016.
More articles on devices:
Zimmer Biomet, J&J, Stryker & more: 15 device company key notes
US Patent Office allows Aurora Spine’s patent for polyaxial ZIP ISP: 4 things to know
Whale Imaging earns FDA approval for next-generation G-Arm — 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
